A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation

Published:2004-06-07 Issue:1 Volume:34 Page:51-56
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hwang W Y K,Koh L-P,Ng H J,Tan P H C,Chuah C T H,Fook S C,Chow H,Tan K W,Wong C,Tan C H,Goh Y-T

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704521.pdf

Reference28 articles.

1. Davidson DE, Grenan MM, Sweeney TR . Biological characteristics of some improved radioprotectors. In: Brady LW (ed.). Radiation Sensitizers. Masson: New York, 1980; pp 309–320.

2. Wasserman TH, Phillips TL, Ross G et al. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by WR-2721. Cancer Clin Trials 1981; 4: 3–6.

3. Yuhas JM, Spellman JM, Culo F . The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin Trials 1980; 3: 211–216.

4. Douay L, Hu C, Giarratana MC, Gorin NC . Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects. Eur J Cancer 1995; 31A (Suppl. 1): S14–S16.

5. Calabro-Jones PM, Fahey RC, Smoluk GD et al. Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721. Int J Radiat Biol 1985; 47: 23–27.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Total Body Irradiation in Stem Cell Transplant;Contemporary Bone Marrow Transplantation;2021

2. Winning the Fight Against Cancer;Annals of the Academy of Medicine, Singapore;2020-11-18

3. Total Body Irradiation in Stem Cell Transplant;Contemporary Bone Marrow Transplantation;2020

4. Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis;Mucosal Immunology;2019-01-15

5. Total Body Irradiation;Clinical Radiation Oncology;2016